North America Liver Fibrosis Treatment Market to 2032
Overview
The North America Liver Fibrosis Treatment Market is expected to reach a 16.87 USD Billion by 2032 and is projected to grow at a CAGR of 10.78% from 2025 to 2032.
Revenue, 2024 (USD Billion)
7.46
Forecast, 2032 (USD Billion)
16.87
CAGR, 2024 - 2032
10.78%
Report Coverage
North America
North America Liver Fibrosis Treatment Market 2018-2032 USD Billion
North America Liver Fibrosis Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 7.46 USD Billion
- Projected Market Size (2032): 16.87 USD Billion
- CAGR (2025-2032): 10.78%
Key Findings of North America Liver Fibrosis Treatment Market
- The North America Liver Fibrosis Treatment Market was valued at 7.46 USD Billion in 2024.
- The North America Liver Fibrosis Treatment Market is likely to grow at a CAGR of 10.78% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Medication in Treatment Type Segment accounted for the largest share of the market with a revenue of 6.13 USD Billion
- The fastest growing segment F2 in Stages Segment grew Fastest with a CAGR of 12.64% during the forecast period from 2024 to 2032.
North America Liver Fibrosis Treatment Market Scope
North America Liver Fibrosis Treatment Market Segmentation & Scope
Treatment Type
- Surgery/Therapy
- Medication
End User
- Others
- Ambulatory and Research Centers
- Clinics
- Specialty Clinics
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Indication
- Others
- Genetic Disorders
- Autoimmune Liver Diseases
- Alcoholic Liver Disease (ALD)
- Hepatitis B & C-Induced Fibrosis
- Non-Alcoholic Steatohepatitis (NASH)
Gender
- Female
- Male
Stages
- F4
- F3
- F1
- F2
North America Liver Fibrosis Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 7.46 USD Billion |
| Market Value in 2032 | 16.87 USD Billion |
| CAGR (2025-2032) | 10.78% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment Type,End User,Distribution Channel,Indication,Gender,Stages |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 7.46 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 6,775.03 USD Million in 2024.
Segments and Scope
-
North America Liver Fibrosis Treatment Market to 2032, By Treatment Type
- Medication is the largest segment in North America Liver Fibrosis Treatment Market to 2032 with a revenue of 6.13 USD Billion in the year 2024.
- Medication is the Fastest growing segment in North America Liver Fibrosis Treatment Market to 2032 with a Growth rate of 10.95 % in forecast period 2025-2032.
-
North America Liver Fibrosis Treatment Market to 2032, By End User
- Hospitals is the largest segment in North America Liver Fibrosis Treatment Market to 2032 with a revenue of 3.66 USD Billion in the year 2024.
- Specialty Clinics is the Fastest growing segment in North America Liver Fibrosis Treatment Market to 2032 with a Growth rate of 10.92 % in forecast period 2025-2032.
-
North America Liver Fibrosis Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Liver Fibrosis Treatment Market to 2032 with a revenue of 5.32 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in North America Liver Fibrosis Treatment Market to 2032 with a Growth rate of 11.16 % in forecast period 2025-2032.
-
North America Liver Fibrosis Treatment Market to 2032, By Indication
- Non-Alcoholic Steatohepatitis (NASH) is the largest segment in North America Liver Fibrosis Treatment Market to 2032 with a revenue of 2.58 USD Billion in the year 2024.
- Non-Alcoholic Steatohepatitis (NASH) is the Fastest growing segment in North America Liver Fibrosis Treatment Market to 2032 with a Growth rate of 12.12 % in forecast period 2025-2032.
-
North America Liver Fibrosis Treatment Market to 2032, By Gender
- Male is the largest segment in North America Liver Fibrosis Treatment Market to 2032 with a revenue of 4.72 USD Billion in the year 2024.
- Male is the Fastest growing segment in North America Liver Fibrosis Treatment Market to 2032 with a Growth rate of 11.33 % in forecast period 2025-2032.
-
North America Liver Fibrosis Treatment Market to 2032, By Stages
- F2 is the largest segment in North America Liver Fibrosis Treatment Market to 2032 with a revenue of 2.42 USD Billion in the year 2024.
- F2 is the Fastest growing segment in North America Liver Fibrosis Treatment Market to 2032 with a Growth rate of 12.64 % in forecast period 2025-2032.
North America Liver Fibrosis Treatment Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Novartis AG | |||
| AbbVie Inc. | |||
| Gilead Sciences, Inc. | |||
| Intercept Pharmaceuticals, Inc. | |||
North America Liver Fibrosis Treatment Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Liver Fibrosis Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Liver Fibrosis Treatment Market is segmented based on Segmentation Treatment Type,End User,Distribution Channel,Indication,Gender,Stages.
North America Liver Fibrosis Treatment Market was valued at USD 7.46(Revenue in USD Billion) in 2024.
North America Liver Fibrosis Treatment Market is projected to grow at a CAGR of 10.78% during the forecast period of 2024 to 2032.
The Medication segment is expected to dominate the North America Liver Fibrosis Treatment Market, holding a largest market share of 6.13 USD Billion in 2024
North America Liver Fibrosis Treatment Market Scope
North America Liver Fibrosis Treatment Market Segmentation & Scope
Treatment Type
- Surgery/Therapy
- Medication
End User
- Others
- Ambulatory and Research Centers
- Clinics
- Specialty Clinics
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Indication
- Others
- Genetic Disorders
- Autoimmune Liver Diseases
- Alcoholic Liver Disease (ALD)
- Hepatitis B & C-Induced Fibrosis
- Non-Alcoholic Steatohepatitis (NASH)
Gender
- Female
- Male
Stages
- F4
- F3
- F1
- F2
Frequently Asked Questions
The North America Liver Fibrosis Treatment Market is segmented based on Segmentation Treatment Type,End User,Distribution Channel,Indication,Gender,Stages.
North America Liver Fibrosis Treatment Market was valued at USD 7.46(Revenue in USD Billion) in 2024.
North America Liver Fibrosis Treatment Market is projected to grow at a CAGR of 10.78% during the forecast period of 2024 to 2032.
The estimated market value of the North America Liver Fibrosis Treatment Market for final year is USD 16.87 (USD Billion).
North America Liver Fibrosis Treatment Market Company Profiling
Frequently Asked Questions
The North America Liver Fibrosis Treatment Market is segmented based on Segmentation Treatment Type,End User,Distribution Channel,Indication,Gender,Stages.
North America Liver Fibrosis Treatment Market was valued at USD 7.46(Revenue in USD Billion) in 2024.
North America Liver Fibrosis Treatment Market is projected to grow at a CAGR of 10.78% during the forecast period of 2024 to 2032.
The estimated market value of the North America Liver Fibrosis Treatment Market for final year is USD 16.87 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 7500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.